Post on 09-Jul-2020
Our missionTo bring about a change in how we protect both us and our world
Residual Barrier Technology Limited (RBT UK) developed a range of disinfectants and applications that are clinically tested to perform better, protect longer, less harmful, save time and money in application.
RBT has developed a disinfectant solution with 3 levels of protection:• Less harmful• Provides up to to 99.999% effectiveness• Residual protection
2
Introduction• RBT Viridis is a water-based, organic and biodegradable product with very effective microbiocidal efficacy on a broad
spectrum of bacteria, viruses and yeasts.
• The major differentiation of Viridis as compared to other disinfectants is the unique RBT technology that enables
the residual efficacy to be much longer lasting than traditional alcohol based disinfectants (up to 4 hours on hands and 24
hours on hard surfaces).
• Viridis tested against highest EN standards in UK/EU and registered under German BAuA. Viridis products have also been
successfully tested in various childcare and dental settings on microorganisms isolated on surfaces as well as on
several antibiotic resistant bacteria isolated from Malaysian hospitals.
• These tests were carried out by the independent laboratory of Sunway University headed by Distinguished Prof Poh Chit Laa,
(Head of the Centre of Virus & Vaccine Research). Prof Poh* is a leading microbiologist / virologist in the region.
* She has published over 100-ISI cited papers and is on the Editorial Board of the Journal of Bioscience and Bioengineering, published by the Society of Biotechnology, Japan.She is also the leading expert in the world on Enterovirus 71.
4
Index
• Overview of RBT Viridis product• Certification• Product data• What is RBT Viridis?• Recent times - Covid19• Handling and storage• Use• Total Solution
5
OverviewProtectUs Viridis has been developed putting life and environment to the foreground of our core values whilst still meeting the rigorous demands of disinfection and deep sanitation, ensuring hygiene.
• 100% Biodegradable ingredients
• 99.999% Effectiveness• Long lasting residual protection
even when dry• Water based / non-flammable• Designed with human safety
in mind
6
RBT
Viridis
ProtectUs
Viridis has been proven to be effective against contamination from:
• EV-71 (HFMD), Norovirus• Staphylococcus aureus• Enterococcus hirae• Escherichia coli• Candida Albicans• Pseudomonas aeruginosa• Listeria monocytogenes
Gram-negative and gram-positive bacteria, viruses and yeast contamination generate cost to industry amounting to billions on an annual basis.
Certification
• CE – Medical device• SAHPRA (South African Health Products Regulatory
Authority) application• Halal certification
7
Product data
100g solution contains the following active ingredients:• Lactic acid: 0.75g• Phenoxyethanol: 2g
8
Chemical-physical DataProperty Value
Form Liquid
Colour Colourless to slightly yellow
Specific Density ~1.0 g/cm3 at 20C
pH 2.5 – 3.2
What is RBT Viridis
• Unique disinfection formulation to maximise efficacy
and user acceptability
• Broad spectrum efficacy
• Non-corrosive to surface materials
• Water-based, biodegradable ingredients
• Continues to kill pathogens when dried using residual
barrier technology
9
• High antimicrobial efficacy
• Long lasting residual barrier protection
• Less harmful & biodegradable
10
Antimicrobial efficacy
Synergetic, water-based mix of:
1. Organic acids
2. Solvent and preservative
3. Surfactants
Each ingredient by itself is bacteriostatic (preservative) or weakly microbial.
Only by combination in the right ratio, all ingredients work together and become highly effective against bacteria, yeast and viruses.
11
Antimicrobial efficacy contd.
12
Efficacy Conditions Concentration Contact time
Bacterial Surface Disinfection
EN 13727 - Pseudomonas aeruginosa, Enterococcus hirae, Staphylococcus aeureus
0.3g/L bovine albumin 5% 1 minute
EN 13727 - Pseudomonas aeruginosa, Enterococcus hirae, Staphylococcus aeureus
3g/L bovine albumin +3g/L sheep erythrocytes 5% 3 minutes
EN 13697 - Pseudomonas aeruginosa, Enterococcus hirae, Staphylococcus aeureus, Escherichia Coli
0.3g/L bovine albumin 5% 1 minute
EN 13697 - Pseudomonas aeruginosa, Enterococcus hirae, Staphylococcus aeureus, Escherichia Coli
3g/L bovine albumin 5% 3 minutes
Yeasticidal - surface disinfection
EN1650 - Candida Albicans 0.3g/L bovine albumin 5% 1 minute
EN13697 - Candida Albicans 0.3g/L bovine albumin 5% 1 minute
EN13697 - Candida Albicans 3g/L bovine albumin 5% 3 minutes
Mycobactericidal
EN14348 - Mycobacterium terrae 0.3g/L bovine albumin 10% 5 minutes
NonEnveloped viruses
EN14476 - Murine norovirus, Strain S99 0.3g/L bovine albumin 5% 2 minutes
Other
Bactericidal residual efficacy 24h residual efficacy tested with dry and wet wear cycles against Staphylococcus aeureus and Escherichia Coli Bactericidal residual efficacy 24h residual efficacy tested with dry and wet wear cycles against Staphylococcus aeureus and Escherichia Coli
Enterovirus (EV-A71) and Dengue virus (DENV)
Viridis was proven to be effective in killing Enterovirus (EV-A71) and Dengue virus (DENV) in a study conducted by Sunway University. Viridis was also found to be effective in protecting mammal cells from infection of these viruses.
5% 5 minutes
• High antimicrobial efficacy
• Long lasting residual barrier protection
• Less harmful & biodegradable
13
Residual protection
Ingredients are kept on surface in their active form after
drying:
• Actives need to be stable, stay in their right ratio and be able to
rehydrate upon recontamination
• No covalent interaction with the surface
Our technology
• Actives preserved in micelles formed by surfactants
• Actives are not easily removed from surface by mechanical action
• Minimal surface modification
• Easily rinsed off
14
Microscope image of RBT product, showing micro network of surface micelles, 1µmx1µm
Residual protectionTesting done according to established industry protocol:
• Dry disinfectant on test surface
• Incubation under ambient conditions for 2h-24h
• Treatment with different amount of wear cycles:
• Dry cycle: Polyester cloth wiped over test surface with defined force
• Wet cycle: Damp polyester cloth wiped over test surface
• Inoculation with suspension containing test organism
• Sampling of surviving organisms and determination of reduction in viable cells
15
• High antimicrobial efficacy
• Long lasting residual barrier protection
• Less harmful & biodegradable
16
Why biodegradable?
OECD 301: Test Guideline describing methods that permit the screening of chemicals for ready biodegradability in an aerobic aqueous medium.
17
Recent times – COVID19Viridis has a proven track record against similar enveloped virus as well as other non-
enveloped virus where it is 100% effective in killing or inhibiting; such as HFMD EV-A71 (non-
enveloped) and DENV (enveloped).
In a lab test conducted at Sunway University, under Prof Poh, 5% Viridis was able to inhibit EV-
A71 in 5 minutes whereas it took 10% Chlorox (highly toxic) to be effective in 60 minutes. EV-
A71 is typically a virus that can survive up to 7 days on surfaces and the current COVID2019
has been reported to exhibit similar survivability rate on surfaces.
18
The Viridis formulation therefore has been proven to inhibit viruses that have the characteristic of survivability on surfaces.
Viridis has been tested to be effective to perform at V-log 4-5 (99.999%) in killing pathogens, over a 24 hour period, with 8 wear cycles, on surfaces.
Use
Areas of use:
• Surface disinfection of hard and sensitive surfaces
• For use on metal, plastics, varnished surfaces, polycarbonate, polysulphone, acrylic glass etc.
19
Ideal for the use in medical facilities
Dilution possibility
• Due to the less toxic, less harmful and non-corrosive advantages, dilution of the product is preferred and economic solution
• Basic dilution process can be applied
• Safe to handle concentrate
20
Dilution possibility contd.
21
Supply concentrate Dilution procedure Apply diluted product
Supply and transport
1000lt concentrate
flowbins to customer /
locations
Suggested dilution
protocol with:
• Dosing pumps and
• Potable water for
dilution procedure
Dosing procedure
Suggested application:
• Spray or
• Fogging
Instructions for use
Dosing procedure
Dosing device for 3% dilution with potable or RO waterBenefits:
• Keeps constant proportional flow rate
• Hydraulic, Volumetric and non-electric
• Dosing proportional to flowrate
• Precision: surface quality optimized with no waste
• Flow rate between main line and sub-main line will remain 10:1 at wide flow rates
• Working pressure up to 8 bar (116 PSI)
• High UV resistance
• High chemical resistance
• Supplied pre - set. No need for calibration
• Excellent dosing repeatability and homogeneity
• Easy to install, operate and maintain, with no electricity risk
22
Instructions to use
1. Ensure area is clean and all dirt remove before Viridi disinfectant is applied.
2. Apply Ready To Use (RTU) solution using spray or fogging from a distance of
approximately 30cm from the surface or equipment
3. The surface or equipment to be treated should be evenly and lightly wetted. Avoid
drenching the equipment with excessive product. There should not be any running
of droplets or drips from the treated areas. Viridis disinfectant is water based and
non hazardous and should be allowed to air dry.
4. Once air-dried, the treated area will be effectively disinfected following a contact
time of 5 minutes.
5. Re-apply on high traffic areas such as touch screens.
24
Total solution benefits
25
Product Method of useEffective microbial efficacy killing 99.999% of microbes (bacteria, viruses & fungi)
High volumes to manufacture from concentrate
Longer residual efficacy protection Economical
Organic, water-based, non-inflammable and biodegradable
Safe to use / dilute
Harmless to the environment, plants, animals and human Re-usable containers – environmental friendly
Does not cause skin dryness unlike alcohol-based disinfectants
Easy to install, operate and maintain, with no electricity risk
Tested on a wide spectrum of pathogens in lab and field settings
Halal certified